Ledger.Open graph →

SEC Form D · filed March 3, 2020

Alcresta Therapeutics, Inc

Offering

$20.0M

Sold

$10.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

WARREN, NJ

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

William Scheinler · Warren, NJExec Steve Dubin · Warren, NJDirector Stephen Kraus · Warren, NJDirector Anastasios Konidaris · Warren, NJExec · Director Alexey Margolin · Warren, NJDirector Matt Lindenberger · Miami, FLExec · Director Jonathan Hong · Miami, FLExec David Kownator · Miami, FLDirector Theresa Mohan · Miami, FLDirector Adib Mattar · Miami, FLDirector Todd Creech · Atlanta, GADirector Daniel Orlando · Warren, NJExec · Director Charles T. Holland · NEW YORK, NYDirector Howard Mergelkamp · Cromwell, CTDirector Fiona P. Mulhall · Dublin, IrelandExec · Director Brian P. Murphy · Darien, CTExec Stephen Pearce · London, United KingdomDirector Todd Creech · Atlanta, GADirector Daniel Orlando · Warren, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗